Christoph H. Westphal, President and CEO at Flex Pharma, Inc. (FLKS), bought 96,116 shares at $11.78 ($1.1M) on 2016-03-21, disclosed to the SEC on 2016-03-23.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.70 | 24,107 | $282K | 25.0% |
| 2 | $11.70 | 24,107 | $282K | 25.0% |
| 3 | $11.78 | 23,951 | $282K | 25.0% |
| 4 | $11.78 | 23,951 | $282K | 25.0% |
| Total | $11.74 avg | 96,116 | $1.1M | 100% |
| Filing → |
| FLKS | BUY | 2016-11-08 | $51K | — | Filing → |
| FLKS | BUY | 2016-11-07 | $51K | — | Filing → |
| FLKS | BUY | 2016-06-24 | $30K | — | Filing → |